Regencell Bioscience Holdings Ltd
For the period ended Jun 30, 2026. Filed Oct 7, 2026.
View on SEC.govAbout this filing
The yearly report of a company based outside the US. It covers much of what a 10-K does, and may follow accounting rules other than US ones.
FY2026 · Filed Oct 7, 2026
RGC$5.270.0%Stored close · as of Nov 6, 2026
Contents
CODE OF ETHICS
Item 16B. CODE OF ETHICS
Our board of directors has adopted a code of business conduct and ethics that applies to our directors, principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions, and employees. A copy of our code of business conduct and ethics is available on our website at https://www.regencellbioscience.com.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.